Sergio García‐Fernández
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 21
-
- Antibiotic Use and Resistance 5
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing 5
- Endocrinology top 5%
- Enterobacteriaceae and Cronobacter Research 5
-
- Nosocomial Infections in ICU 3
-
- Clostridium difficile and Clostridium perfringens research 10
-
- Antibiotics Pharmacokinetics and Efficacy 9
-
- Microscopic Colitis 8
- Co-authors
- Rafael CantónMaría‐Isabel MorosiniJavier CoboPatricia Ruíz-GarbajosaFrancesc MarcoJordi VilàMaría García-CastilloRosa Escudero-Sánchez
- Journals
- Angewandte Chemie International Edition (1 paper)Scientific Reports (1 paper)Journal of Clinical Microbiology (1 paper)
- Partner nations
- SpainGermanyNetherlands
In The Last Decade
Sergio García‐Fernández
32 papers receiving 514 citations
Peers
Comparison fields: 5 of 66
- Molecular Medicine 237
- Applied Microbiology and Biotechnology 86
- Clinical Biochemistry 97
- Endocrinology 73
- Critical Care and Intensive Care Medicine 67
Countries citing papers authored by Sergio García‐Fernández
This map shows the geographic impact of Sergio García‐Fernández's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio García‐Fernández with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio García‐Fernández more than expected).
Fields of papers citing papers by Sergio García‐Fernández
This network shows the impact of papers produced by Sergio García‐Fernández. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio García‐Fernández. The network helps show where Sergio García‐Fernández may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sergio García‐Fernández, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 11 | |
| 7 | 2022 | 3 | |
| 8 | 2022 | 6 | |
| 9 | 2021 | 5 | |
| 10 | 2021 | 7 | |
| 11 | 2021 | 7 | |
| 12 | 2020 | 20 | |
| 13 | 2020 | 12 | |
| 14 | 2020 | 17 | |
| 15 | 2020 | 68 | |
| 16 | 2019 | 37 | |
| 17 | 2019 | 22 | |
| 18 | 2018 | 29 | |
| 19 | 2017 | 5 | |
| 20 | 2016 | 16 |
About Sergio García‐Fernández
Sergio García‐Fernández is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Endocrinology, having authored 34 papers that have together received 523 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (21 papers), Clostridium difficile and Clostridium perfringens research (10 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers), Microscopic Colitis (8 papers), Enterobacteriaceae and Cronobacter Research (5 papers), Antibiotic Use and Resistance (5 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Nosocomial Infections in ICU (3 papers). The work is most often cited by research in Molecular Medicine (237 citations), Applied Microbiology and Biotechnology (86 citations) and Clinical Biochemistry (97 citations). Sergio García‐Fernández has collaborated with scholars based in Spain, Germany and Netherlands. Frequent co-authors include Rafael Cantón, María‐Isabel Morosini, Javier Cobo, Patricia Ruíz-Garbajosa, Francesc Marco, Jordi Vilà, María García-Castillo, Rosa Escudero-Sánchez, Manuel Ponce‐Alonso and Desirée Gijón. Their work appears in journals such as Angewandte Chemie International Edition, Scientific Reports and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.